Honeywell International’s GSK GSK Stock Holding History

Honeywell International’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-280,000	Closed	-$15.2M	–	185
2016 Q2	$15.2M	Sell	280,000 -80,000	-22%	-$4.21M	0.39%	99
2016 Q1	$18.2M	Buy	+360,000	New	+$17.9M	0.46%	92
2015 Q2	–	Sell	-829,680	Closed	-$47.9M	–	186
2015 Q1	$47.9M	Sell	829,680 -321,760	-28%	-$18.4M	1.13%	20
2014 Q4	$61.5M	Buy	1,151,440 +286,640	+33%	+$16M	1.4%	10
2014 Q3	$49.7M	Buy	+864,800	New	+$53M	1.17%	19
2013 Q4	–	Sell	-228,000	Closed	-$14.3M	–	173
2013 Q3	$14.3M	Sell	228,000 -472,000	-67%	-$30.4M	0.37%	110
2013 Q2	$43.7M	Buy	+700,000	New	+$44.4M	1.19%	22

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Honeywell International's GSK Position: Q3 2016 in Review

Honeywell International sold out of GSK (GSK) in Q3 2016, closing a stake of 280,000 shares — an estimated $15.2M sold.

Honeywell International first reported a position in GSK in Q2 2013 and held it in 7 quarters. The position peaked at $61.5M in Q4 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Honeywell International reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
Honeywell International sold 280,000 GSK shares in Q3 2016, an estimated $15.2M.
Honeywell International first reported a position in GSK in Q2 2013 and held it in 7 quarters.
Honeywell International's GSK position peaked at $61.5M in Q4 2014.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Honeywell International's 13F filing for Q3 2016, filed 2 Nov 2016.